The most influential meeting on HTA for pharmaceutical products
At Health Technology Assessment World Europe thought leaders in HTA from leading biopharmaceutical companies, government agencies, academic institutions, contract service organisations and consultancies, will convene to discuss pioneering HTA strategy.
Come to Health Technology Assessment World and learn:
• HTA policy and practice in Europe, USA and rest of the World
• HTA in reimbursement decisions
•Cooperation between regulatory bodies and HTA agencies
• How to demonstrate comparative effectiveness and outcomes research
• Case studies of HTA policy, practice and assessment methods
• HTA for speciality and high priced drugs
• Value based pricing, risk sharing schemes and reimbursement
•Role of patients in HTA
Who should attend:
This event will be attended by pharmaceutical and biotech professionals working in the following departments:
- HTA
- Market Access
- Health Economics
- Outcomes Research
- Health Policy
- Epidemiology
- Reimbursement
- Pricing
- Pharmacoeconomics
Who should sponsor:
Health Technology Assessment World is a unique opportunity for CRO, consultancy or software/data suppliers
- Contract Research Organisation
- Consultants
- Niche Contract Research Organisations
- Communications
- IT / software/data providers
Don’t just take our word for it:
“The sessions were thought provoking and an indication of opps/threats down the road, and how authorities are revising policy with change and what the industry is trying to do to neutralize or keep up with demands.”
PRA Manager NPP, Eli Lilly
“Very first-hand info from agencies, HTA/PQR challenges, industry views, political insights. Very good networking possibilities.”
Project Director, Global HEOR, INTENDIS GmbH
